Vascular Tissue Engineering is a multidisciplinary field that combines principles of engineering, biology, and materials science to create functional and implantable blood vessels. The goal is to develop innovative strategies to replace or repair damaged blood vessels, addressing challenges in cardiovascular diseases, vascular trauma, and organ transplantation. Various approaches are employed in vascular tissue engineering, including the use of biomaterial scaffolds, cell sources, and bioactive molecules. Biocompatible materials such as polymers and hydrogels serve as scaffolds, providing a framework for cell attachment, proliferation, and tissue formation. Cells play a crucial role in vascular tissue engineering, with endothelial cells and smooth muscle cells often used to populate the scaffold. Endothelial cells form the inner lining of blood vessels, promoting blood compatibility, while smooth muscle cells contribute to vessel structure and contractility. Bioactive molecules, including growth factors and cytokines, are incorporated into the engineered constructs to regulate cellular behavior, promote vascularization, and enhance tissue integration. Bioprinting technologies enable the precise deposition of cells and biomaterials, allowing the creation of complex three-dimensional vascular structures with spatial accuracy. Vascular tissue engineering holds promise for developing off-the-shelf vascular grafts and personalized solutions tailored to individual patient needs. Success in this field may revolutionize treatments for vascular diseases and improve outcomes in cardiovascular surgeries, ultimately contributing to advancements in regenerative medicine and patient care.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States